Transplant commercialism and organ trafficking: the Declaration of Istanbul with special relevance to disadvantaged populations living with kidney disease.
This paper provides a historical perspective on organ trafficking and transplant commercialism, an overview of the Declaration of Istanbul [1, 2], and an update on current state. We highlight the importance of this problem pertaining to disadvantaged populations living with or at risk for kidney disease. It was presented during the Kidney Disease in Disadvantaged Populations Satellite Symposium of the World Congress of Nephrology in Hong Kong 2013 (www.theisn.org).
University of British Columbia, Vancouver, Canada, Transplant Unit Groote Schuur Hospital, University of Cape Town, South Africa, South Africa, Dubai Medical College, Dubai, United Arab Emirates, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa, and Karolinska Institute, Stockholm, Sweden.
Adeera
A
Levin
Elmi
E
Muller
Mona
M
Alrukhaimi
Saralah
S
Naicker
Annika
A
Tibbel
D003132:Commerce / Q000331:legislation & jurisprudence*; D006801:Humans; D007674:Kidney Diseases / Q000601:surgery*; D064877:Organ Trafficking / Q000331:legislation & jurisprudence*; D009927:Tissue and Organ Procurement / Q000331:legislation & jurisprudence*; D014421:Turkey; D035862:Vulnerable Populations